 | • レポートコード：MRC-IM31166 • 出版社/出版日：IMARC / 2023年3月 • レポート形態：英文、PDF、147ページ • 納品方法：Eメール • 産業分類：バイオ |
| Single User | ￥374,850 (USD2,499) | ▷ お問い合わせ |
| Enterprisewide | ￥674,850 (USD4,499) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| IMARC社の本調査レポートでは、2022年に682億ドルであった世界のバイオマーカー市場規模が、2028年までに1,398億ドルに拡大し、予測期間中にCAGR11.5%で成長すると予想しています。本書は、バイオマーカーの世界市場を調査・分析し、序論、範囲・調査手法、エグゼクティブサマリー、イントロダクション、製品別（消耗品、サービス、ソフトウェア）分析、種類別（エフィカシーバイオマーカー、毒性バイオマーカー、バリデーションバイオマーカー）分析、疾患別（がん、心血管系疾患、神経疾患、免疫疾患、その他）分析、用途別（診断薬、創薬・開発、個別化医療、その他）分析、地域別（北米、アジア、欧州、中南米、中東・アフリカ）分析、SWOT分析（強み・弱み・機会・脅威）、バリューチェーン分析、ポーターズファイブフォース分析、価格分析、競争状況などの項目を整理しています。また、本書には、Agilent Technologies Inc.、Bio-Rad Laboratories Inc.、Charles River Laboratories International Inc.、Epigenomics AG、Eurofins Scientific SE、Merck KGaA、Perkinelmer Inc.、Qiagen N.V、Quanterix Corporation、SphingoTec GmbH and Thermo Fisher Scientific Inc.などの企業情報が含まれています。 ・序論 ・範囲・調査手法 ・エグゼクティブサマリー ・イントロダクション ・世界のバイオマーカー市場規模：製品別 - 消耗品の市場規模 - サービスの市場規模 - ソフトウェアの市場規模 ・世界のバイオマーカー市場規模：種類別 - エフィカシーバイオマーカーの市場規模 - 毒性バイオマーカーの市場規模 - バリデーションバイオマーカーの市場規模 ・世界のバイオマーカー市場規模：疾患別 - がんの市場規模 - 心血管系疾患の市場規模 - 神経疾患の市場規模 - 免疫疾患の市場規模 - その他の市場規模 ・世界のバイオマーカー市場規模：用途別 - 診断薬における市場規模 - 創薬・開発における市場規模 - 個別化医療における市場規模 - その他における市場規模 ・世界のバイオマーカー市場規模：地域別 - 北米のバイオマーカー市場規模 - アジアのバイオマーカー市場規模 - 欧州のバイオマーカー市場規模 - 中南米のバイオマーカー市場規模 - 中東・アフリカのバイオマーカー市場規模 ・SWOT分析（強み・弱み・機会・脅威） ・バリューチェーン分析 ・ポーターズファイブフォース分析 ・価格分析 ・競争状況 |
Market Overview:
The global biomarkers market size reached US$ 68.2 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 139.8 Billion by 2028, exhibiting a growth rate (CAGR) of 11.5% during 2023-2028.
Biomarkers, also known as biological markers, are molecules or genes that are used as indicators of the health or status of an organ, tissue, or cell. In addition to blood and bodily fluids, biomarkers are also found in tissues. In the discovery and development of new drugs, biomarkers are used for risk assessment, molecular diagnostics, disease diagnosis, DNA fingerprinting, and eliminating complexity. As a result, they play a crucial role in improving the drug development process, drug validation and testing, sample preparation and assay development. Biomarkers are often integrated with key imaging technologies that can provide clear images of oncology tumors and other problems while also eliminating the possibility of radiation exposure during CT scans and MRI scans.
Biomarkers Market Trends:
The market is majorly driven by the rising incidences of numerous chronic diseases among the masses, particularly in the geriatric population. In addition to this, the increasing implementation of biomarkers in infectious disease diagnosis is propelling the market. Moreover, continual developments in biomarker-based diagnostics, such as biomarker signatures resulting in faster drug development, non-invasive testing, and early diagnosis, are also creating a positive market outlook. In line with this, the rapid utilization of biomarkers in the development of companion diagnostics to identify drug target molecules is providing an impetus to the market. Also, the escalating demand for personalized medicine, along with a paradigm shift toward biomarker studies from conventional pathophysiology and epidemiology methods, is fueling the market. Furthermore, a considerable rise in the number of contract research organizations facilitating cost-efficient clinical trials are creating a positive market outlook. Some of the other factors contributing to the market include extensive research and development (R&D) activities and the increasing medical expenditure.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global biomarkers market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on product, type, disease, application and end user.
Breakup by Product:
Consumables
Services
Software
Breakup by Type:
Efficacy Biomarkers
Safety Biomarkers
Validation Biomarkers
Breakup by Disease:
Cancer
Cardiovascular Disorders
Neurological Disorders
Immunological Disorders
Renal Disorders
Others
Breakup by Application:
Diagnostics
Drug Discovery and Development
Personalized Medicine
Others
Breakup by End User:
Pharmaceutical and Biotechnology Companies
Diagnostic and Research Laboratories
Hospitals and Specialty Clinics
Others
Breakup by Region:
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Agilent Technologies Inc., Bio-Rad Laboratories Inc., Charles River Laboratories International Inc., Epigenomics AG, Eurofins Scientific SE, Merck KGaA, Perkinelmer Inc., Qiagen N.V, Quanterix Corporation, SphingoTec GmbH and Thermo Fisher Scientific Inc.
Key Questions Answered in This Report
1. What was the size of the global biomarkers market in 2022?
2. What is the expected growth rate of the global biomarkers market during 2023-2028?
3. What are the key factors driving the global biomarkers market?
4. What has been the impact of COVID-19 on the global biomarkers market?
5. What is the breakup of the global biomarkers market based on the product?
6. What is the breakup of the global biomarkers market based on the type?
7. What is the breakup of the global biomarkers market based on disease?
8. What is the breakup of the global biomarkers market based on the application?
9. What is the breakup of the global biomarkers market based on the end user?
10. What are the key regions in the global biomarkers market?
11. Who are the key players/companies in the global biomarkers market?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Biomarkers Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Product
6.1 Consumables
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Services
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Software
6.3.1 Market Trends
6.3.2 Market Forecast
7 Market Breakup by Type
7.1 Efficacy Biomarkers
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Safety Biomarkers
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Validation Biomarkers
7.3.1 Market Trends
7.3.2 Market Forecast
8 Market Breakup by Disease
8.1 Cancer
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Cardiovascular Disorders
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Neurological Disorders
8.3.1 Market Trends
8.3.2 Market Forecast
8.4 Immunological Disorders
8.4.1 Market Trends
8.4.2 Market Forecast
8.5 Renal Disorders
8.5.1 Market Trends
8.5.2 Market Forecast
8.6 Others
8.6.1 Market Trends
8.6.2 Market Forecast
9 Market Breakup by Application
9.1 Diagnostics
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Drug Discovery and Development
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Personalized Medicine
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Others
9.4.1 Market Trends
9.4.2 Market Forecast
10 Market Breakup by End User
10.1 Pharmaceutical and Biotechnology Companies
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Diagnostic and Research Laboratories
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Hospitals and Specialty Clinics
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Others
10.4.1 Market Trends
10.4.2 Market Forecast
11 Market Breakup by Region
11.1 North America
11.1.1 United States
11.1.1.1 Market Trends
11.1.1.2 Market Forecast
11.1.2 Canada
11.1.2.1 Market Trends
11.1.2.2 Market Forecast
11.2 Asia-Pacific
11.2.1 China
11.2.1.1 Market Trends
11.2.1.2 Market Forecast
11.2.2 Japan
11.2.2.1 Market Trends
11.2.2.2 Market Forecast
11.2.3 India
11.2.3.1 Market Trends
11.2.3.2 Market Forecast
11.2.4 South Korea
11.2.4.1 Market Trends
11.2.4.2 Market Forecast
11.2.5 Australia
11.2.5.1 Market Trends
11.2.5.2 Market Forecast
11.2.6 Indonesia
11.2.6.1 Market Trends
11.2.6.2 Market Forecast
11.2.7 Others
11.2.7.1 Market Trends
11.2.7.2 Market Forecast
11.3 Europe
11.3.1 Germany
11.3.1.1 Market Trends
11.3.1.2 Market Forecast
11.3.2 France
11.3.2.1 Market Trends
11.3.2.2 Market Forecast
11.3.3 United Kingdom
11.3.3.1 Market Trends
11.3.3.2 Market Forecast
11.3.4 Italy
11.3.4.1 Market Trends
11.3.4.2 Market Forecast
11.3.5 Spain
11.3.5.1 Market Trends
11.3.5.2 Market Forecast
11.3.6 Russia
11.3.6.1 Market Trends
11.3.6.2 Market Forecast
11.3.7 Others
11.3.7.1 Market Trends
11.3.7.2 Market Forecast
11.4 Latin America
11.4.1 Brazil
11.4.1.1 Market Trends
11.4.1.2 Market Forecast
11.4.2 Mexico
11.4.2.1 Market Trends
11.4.2.2 Market Forecast
11.4.3 Others
11.4.3.1 Market Trends
11.4.3.2 Market Forecast
11.5 Middle East and Africa
11.5.1 Market Trends
11.5.2 Market Breakup by Country
11.5.3 Market Forecast
12 SWOT Analysis
12.1 Overview
12.2 Strengths
12.3 Weaknesses
12.4 Opportunities
12.5 Threats
13 Value Chain Analysis
14 Porters Five Forces Analysis
14.1 Overview
14.2 Bargaining Power of Buyers
14.3 Bargaining Power of Suppliers
14.4 Degree of Competition
14.5 Threat of New Entrants
14.6 Threat of Substitutes
15 Price Analysis
16 Competitive Landscape
16.1 Market Structure
16.2 Key Players
16.3 Profiles of Key Players
16.3.1 Agilent Technologies Inc.
16.3.1.1 Company Overview
16.3.1.2 Product Portfolio
16.3.1.3 Financials
16.3.1.4 SWOT Analysis
16.3.2 Bio-Rad Laboratories Inc.
16.3.2.1 Company Overview
16.3.2.2 Product Portfolio
16.3.2.3 Financials
16.3.2.4 SWOT Analysis
16.3.3 Charles River Laboratories International Inc.
16.3.3.1 Company Overview
16.3.3.2 Product Portfolio
16.3.3.3 Financials
16.3.3.4 SWOT Analysis
16.3.4 Epigenomics AG
16.3.4.1 Company Overview
16.3.4.2 Product Portfolio
16.3.4.3 Financials
16.3.4.4 SWOT Analysis
16.3.5 Eurofins Scientific SE
16.3.5.1 Company Overview
16.3.5.2 Product Portfolio
16.3.5.3 Financials
16.3.5.4 SWOT Analysis
16.3.6 Merck KGaA
16.3.6.1 Company Overview
16.3.6.2 Product Portfolio
16.3.6.3 Financials
16.3.6.4 SWOT Analysis
16.3.7 Perkinelmer Inc.
16.3.7.1 Company Overview
16.3.7.2 Product Portfolio
16.3.7.3 Financials
16.3.7.4 SWOT Analysis
16.3.8 Qiagen N.V
16.3.8.1 Company Overview
16.3.8.2 Product Portfolio
16.3.8.3 Financials
16.3.8.4 SWOT Analysis
16.3.9 Quanterix Corporation
16.3.9.1 Company Overview
16.3.9.2 Product Portfolio
16.3.9.3 Financials
16.3.10 SphingoTec GmbH
16.3.10.1 Company Overview
16.3.10.2 Product Portfolio
16.3.11 Thermo Fisher Scientific Inc.
16.3.11.1 Company Overview
16.3.11.2 Product Portfolio
16.3.11.3 Financials
16.3.11.4 SWOT Analysis
Figure 2: Global: Biomarkers Market: Sales Value (in Billion US$), 2017-2022
Figure 3: Global: Biomarkers Market Forecast: Sales Value (in Billion US$), 2023-2028
Figure 4: Global: Biomarkers Market: Breakup by Product (in %), 2022
Figure 5: Global: Biomarkers Market: Breakup by Type (in %), 2022
Figure 6: Global: Biomarkers Market: Breakup by Disease (in %), 2022
Figure 7: Global: Biomarkers Market: Breakup by Application (in %), 2022
Figure 8: Global: Biomarkers Market: Breakup by End User (in %), 2022
Figure 9: Global: Biomarkers Market: Breakup by Region (in %), 2022
Figure 10: Global: Biomarkers (Consumables) Market: Sales Value (in Million US$), 2017 & 2022
Figure 11: Global: Biomarkers (Consumables) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 12: Global: Biomarkers (Services) Market: Sales Value (in Million US$), 2017 & 2022
Figure 13: Global: Biomarkers (Services) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 14: Global: Biomarkers (Software) Market: Sales Value (in Million US$), 2017 & 2022
Figure 15: Global: Biomarkers (Software) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 16: Global: Biomarkers (Efficacy Biomarkers) Market: Sales Value (in Million US$), 2017 & 2022
Figure 17: Global: Biomarkers (Efficacy Biomarkers) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 18: Global: Biomarkers (Safety Biomarkers) Market: Sales Value (in Million US$), 2017 & 2022
Figure 19: Global: Biomarkers (Safety Biomarkers) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 20: Global: Biomarkers (Validation Biomarkers) Market: Sales Value (in Million US$), 2017 & 2022
Figure 21: Global: Biomarkers (Validation Biomarkers) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 22: Global: Biomarkers (Cancer) Market: Sales Value (in Million US$), 2017 & 2022
Figure 23: Global: Biomarkers (Cancer) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 24: Global: Biomarkers (Cardiovascular Disorders) Market: Sales Value (in Million US$), 2017 & 2022
Figure 25: Global: Biomarkers (Cardiovascular Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 26: Global: Biomarkers (Neurological Disorders) Market: Sales Value (in Million US$), 2017 & 2022
Figure 27: Global: Biomarkers (Neurological Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 28: Global: Biomarkers (Immunological Disorders) Market: Sales Value (in Million US$), 2017 & 2022
Figure 29: Global: Biomarkers (Immunological Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 30: Global: Biomarkers (Renal Disorders) Market: Sales Value (in Million US$), 2017 & 2022
Figure 31: Global: Biomarkers (Renal Disorders) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 32: Global: Biomarkers (Other Diseases) Market: Sales Value (in Million US$), 2017 & 2022
Figure 33: Global: Biomarkers (Other Diseases) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 34: Global: Biomarkers (Diagnostics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 35: Global: Biomarkers (Diagnostics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 36: Global: Biomarkers (Drug Discovery and Development) Market: Sales Value (in Million US$), 2017 & 2022
Figure 37: Global: Biomarkers (Drug Discovery and Development) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 38: Global: Biomarkers (Personalized Medicine) Market: Sales Value (in Million US$), 2017 & 2022
Figure 39: Global: Biomarkers (Personalized Medicine) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 40: Global: Biomarkers (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
Figure 41: Global: Biomarkers (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 42: Global: Biomarkers (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2017 & 2022
Figure 43: Global: Biomarkers (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 44: Global: Biomarkers (Diagnostic and Research Laboratories) Market: Sales Value (in Million US$), 2017 & 2022
Figure 45: Global: Biomarkers (Diagnostic and Research Laboratories) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 46: Global: Biomarkers (Hospitals and Specialty Clinics) Market: Sales Value (in Million US$), 2017 & 2022
Figure 47: Global: Biomarkers (Hospitals and Specialty Clinics) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 48: Global: Biomarkers (Other End Users) Market: Sales Value (in Million US$), 2017 & 2022
Figure 49: Global: Biomarkers (Other End Users) Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 50: North America: Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 51: North America: Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 52: United States: Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 53: United States: Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 54: Canada: Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 55: Canada: Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 56: Asia-Pacific: Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 57: Asia-Pacific: Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 58: China: Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 59: China: Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 60: Japan: Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 61: Japan: Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 62: India: Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 63: India: Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 64: South Korea: Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 65: South Korea: Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 66: Australia: Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 67: Australia: Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 68: Indonesia: Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 69: Indonesia: Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 70: Others: Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 71: Others: Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 72: Europe: Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 73: Europe: Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 74: Germany: Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 75: Germany: Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 76: France: Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 77: France: Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 78: United Kingdom: Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 79: United Kingdom: Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 80: Italy: Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 81: Italy: Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 82: Spain: Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 83: Spain: Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 84: Russia: Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 85: Russia: Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 86: Others: Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 87: Others: Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 88: Latin America: Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 89: Latin America: Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 90: Brazil: Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 91: Brazil: Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 92: Mexico: Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 93: Mexico: Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 94: Others: Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 95: Others: Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 96: Middle East and Africa: Biomarkers Market: Sales Value (in Million US$), 2017 & 2022
Figure 97: Middle East and Africa: Biomarkers Market: Breakup by Country (in %), 2022
Figure 98: Middle East and Africa: Biomarkers Market Forecast: Sales Value (in Million US$), 2023-2028
Figure 99: Global: Biomarkers Industry: SWOT Analysis
Figure 100: Global: Biomarkers Industry: Value Chain Analysis
Figure 101: Global: Biomarkers Industry: Porter's Five Forces Analysis